Institute for Bioscience and Biotechnology Research, University of Maryland, 9600 Gudelsky Dr., Rockville, MD 20850, United States.
Institute for Bioscience and Biotechnology Research, University of Maryland, 9600 Gudelsky Dr., Rockville, MD 20850, United States.
Mater Sci Eng C Mater Biol Appl. 2020 Jan;106:110179. doi: 10.1016/j.msec.2019.110179. Epub 2019 Sep 9.
Nanoparticulate and water-soluble formulations of ionic polyphosphazenes and protein cargo - lysozyme (LYZ) were prepared by their self-assembly in aqueous solutions at near physiological pH (pH 7.4) in the presence and absence of an ionic cross-linker - spermine tetrahydrochloride. Efficiency of LYZ encapsulation, physico-chemical characteristics of formulations, and the effect of reaction parameters were investigated using asymmetric flow field flow fractionation (AF4) and dynamic light scattering (DLS) methods. The effect of both polymer formulations on encapsulated LYZ was evaluated using soluble oligosaccharide substrate, whereas their ability to present the protein to cellular surfaces was assessed by measuring enzymatic activity of encapsulated LYZ against Micrococcus lysodeikticus cells. It was found that both soluble and cross-linked polymer matrices reduce lysis of bacterial cells by LYZ, whereas activity of encapsulated protein against oligosaccharide substrate remained practically unchanged indicating no adverse effect of polyphosphazene on protein integrity. Moreover, nanoparticulate formulations display distinctly different behavior in cellular assays when compared to their soluble counterparts. LYZ encapsulated in polyphosphazene nanoparticles shows approximately 2.5-fold higher activity in its ability to lyse cells as compared with water-soluble LYZ-PCPP formulations. A new approach to PEGylation of polyphosphazene nanoparticles was also developed. The method utilizes a new ionic polyphosphazene derivative, which contains graft (polyethylene glycol) chains. PEGylation allows for an improved control over the size of nanoparticles and broader modulation of their cross-linking density, while still permitting for protein presentation to cellular substrates.
离子型聚膦嗪纳米颗粒和水凝胶载体制剂的制备-溶菌酶(LYZ),通过其在近生理 pH(pH 7.4)的水溶液中的自组装来制备,在存在和不存在离子交联剂-精胺四盐酸盐的情况下。采用不对称流场流分离(AF4)和动态光散射(DLS)方法研究了 LYZ 包封效率、制剂的物理化学特性以及反应参数的影响。使用可溶性寡糖底物评估了两种聚合物制剂对包封 LYZ 的影响,而通过测量包封 LYZ 对微球菌细胞的酶活性,评估了它们向细胞表面呈现蛋白质的能力。结果发现,两种可溶性和交联聚合物基质都降低了 LYZ 对细菌细胞的裂解作用,而包封蛋白对寡糖底物的活性几乎保持不变,表明聚膦嗪对蛋白质完整性没有不利影响。此外,与可溶性制剂相比,纳米颗粒制剂在细胞测定中表现出明显不同的行为。与水溶性 LYZ-PCPP 制剂相比,包封在聚膦嗪纳米颗粒中的 LYZ 具有约 2.5 倍更高的裂解细胞能力。还开发了一种新的聚膦嗪纳米颗粒聚乙二醇化方法。该方法利用一种新的离子型聚膦嗪衍生物,其含有接枝(聚乙二醇)链。PEG 化允许更好地控制纳米颗粒的大小并更广泛地调节其交联密度,同时仍允许蛋白质向细胞底物呈现。